Skip to the content
Next generation gene therapy vectorslogo darklogo light
  • Home
  • About
  • Science & Platform
  • Team
  • News
  • Contact
Next generation gene therapy vectors
  • Home
  • About
  • Science & Platform
  • Team
  • News
  • Contact
HomeLeft Sidebar
June 2, 2022

rAAVen and Myrtelle Partner to Develop Oligodendrocyte-Targeting AAVs

rAAVen The

November 1, 2022

Patrick Aldrin-Kirk Joins rAAVen as Chief Scientific Officer

rAAVen The

May 24, 2023

rAAVen and PCI Biotech Launch Photochemical Lysis Project

rAAVen The

June 10, 2023

rAAVen to Present at Viral Vector Summit in Amsterdam

rAAVen The

November 7, 2023

Lena Mårtensson Joins rAAVen Board of Directors

Lena Mårt

January 18, 2024

rAAVen and Myrtelle Expand Partnership for Capsid Validation

rAAVen The

Prev 01 02 Next

Categories

  • News

Tags

Follow us

LinkedIn

© 2022 rAAVen Therapeutics

Contact Us


a
Back to top

Otaru tech

New generation of technology and design. Find us on social media and always stay updated.

t
t
t
t
s
facebook Twitter linkedin